Managing skin health in obese children with spina bifida: an overview and case study

Kathleen M Murphy1

  • 1Pediatric Surgery Clinic, Texas Children's Hospital, Houston, Texas, USA. kmmurphy@texaschildrenshospital.org

Ostomy/Wound Management
|February 6, 2008
PubMed

Insights

Managing chronic wounds in obese children, particularly those with spina bifida, requires a comprehensive approach. A multidisciplinary team is crucial for effective skin integrity restoration and patient care.

Area of Science:

  • Pediatric healthcare
  • Wound management
  • Congenital anomalies

Background:

  • Neural tube deficits, including spina bifida, are common congenital anomalies despite reduced incidence due to prenatal folic acid awareness.
  • Obese children with spina bifida face unique challenges in chronic wound and skin care.
  • Management requires addressing physical limitations, sensory deficits, limb weakness, and psychosocial needs.

Observation:

  • Skin breakdown is a frequent and recurring issue for spina bifida patients and their families.
  • Wound etiology is multifactorial, influenced by physical, social, and environmental factors.
  • A case study highlights the complexities of wound occurrence and recurrence in this population.

Findings:

  • A multidisciplinary team approach involving physicians, therapists, nutritionists, social workers, and wound care specialists is most effective for restoring skin integrity.
  • Education for patients, families, and healthcare providers is essential for managing complex care needs.

Implications:

  • Highlights the need for evidence-based care strategies tailored to obese children with spina bifida.
  • Emphasizes the importance of a collaborative, team-based approach in pediatric wound care.
  • Underscores the necessity for further research into specific conditions affecting this vulnerable population.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...